Tenax Therapeutics
TENX
16 hedge funds and large institutions have $35.9M invested in Tenax Therapeutics in 2015 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
14% more capital invested
Capital invested by funds: $31.4M → $35.9M (+$4.43M)
16% less funds holding
Funds holding: 19 → 16 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.58M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$525K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$105K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$246K |
| 2 |
Axa
Paris,
France
|
-$164K |
| 3 |
Morgan Stanley
New York
|
-$105K |
| 4 |
Millennium Management
New York
|
-$94K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$46K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIG
26
American International Group
New York
| $4.24K | – | – | – |
|
|
KCM
27
Karp Capital Management
Sausalito,
California
| $2K | – | – | – |
|
28
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
IWMPD
29
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| $1K | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
31
D.E. Shaw & Co
New York
| – | -$246K | -2 | Closed |
|
|
32
Axa
Paris,
France
| – | -$164K | -1 | Closed |
|
|
33
Millennium Management
New York
| – | -$94K | -1 | Closed |
|
|
AGM
34
Alpine Global Management
New York
| – | -$43K | – | – |
|
|
35
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$46K | – | – |
|
TENX Hedge Fund Activity: Q1 2015 in Review
16 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2015, worth a combined $35.9M — up 14% from $31.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TENX and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, adding an estimated $1.58M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $246K sold.
- 16 institutional investors held Tenax Therapeutics (TENX) as of Q1 2015, down from 19 in Q4 2014.
- Funds reported $35.9M of Tenax Therapeutics stock for Q1 2015, up 14% quarter-over-quarter.
- 1 fund opened new Tenax Therapeutics positions in Q1 2015 and 4 closed out, a net change of -3 holders.
- The largest Tenax Therapeutics buyer in Q1 2015 was Sabby Management, an estimated $1.58M added.
- The largest Tenax Therapeutics seller in Q1 2015 was D.E. Shaw & Co, an estimated $246K sold.
Based on aggregated 13F filings for Q1 2015.